MarketsStocksANG
AN

ANG Lifesciences India Ltd

NSE: ANGBSE: 540694Healthcare
Download Research Report7-page PDF
29.50
+1.06%
NSE · auto-updates while market open
Mkt Cap
₹38 Cr
P / E
-
P / B
0.7
ROE
-19.0%
52W High
₹39.70
52W Low
₹17.63
Key Metrics
Market Cap
₹38 Cr
P / E
-
P / B
0.72
EV / EBITDA
158.28
ROCE
-3.7%
ROE
-19.0%
Debt / Equity
1.47
Book Value
₹40.50
EPS
-
Div Yield
0.0%
Face Value
-
Promoter Holding
70.6%
Revenue · ₹ Cr
127
FY20
154
FY21
354
FY22
220
FY23
146
FY24
93
FY25
93
FY26
Net Profit · ₹ Cr
0
0
40
0
-10
-12
-11
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹10.9
₹11.8
₹39.1
₹0.4
₹-7.6
FY19FY20FY22FY23FY24
Q1 2026 snapshot
Sales
₹24 Cr
Operating profit
-
OPM
-
Net profit
₹-1 Cr
EPS
-
Scorecard · 7 axes
Quality
Bad
25/100
Valuation
-
Growth
Bad
-14.2%
Profitability
Bad
-11.3%
Performance
Weak
+0.0%
Entry Point
Good
74%
Red Flags
Strong
0 flags
Shareholding Pattern
70.6%Promoter
Promoter70.6%
Public29.4%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue24.4617.4724.6926.1818.8923.67
Net Profit-5.191-2.061-2.006-2.947-4.75-1.382
NPM %-21.2%-11.8%-8.1%-11.3%-25.1%-5.8%
AlertPre-trade